ACETAMINOPHEN AND IBUPROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acetaminophen And Ibuprofen, and what generic alternatives are available?
Acetaminophen And Ibuprofen is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Glenmark Pharms Ltd, Granules, L Perrigo Co, and Marksans Pharma. and is included in six NDAs.
The generic ingredient in ACETAMINOPHEN AND IBUPROFEN is acetaminophen; ibuprofen. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Ibuprofen
A generic version of ACETAMINOPHEN AND IBUPROFEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN AND IBUPROFEN?
- What are the global sales for ACETAMINOPHEN AND IBUPROFEN?
- What is Average Wholesale Price for ACETAMINOPHEN AND IBUPROFEN?
Summary for ACETAMINOPHEN AND IBUPROFEN
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 33 |
Clinical Trials: | 243 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACETAMINOPHEN AND IBUPROFEN at DailyMed |
![ACETAMINOPHEN AND IBUPROFEN drug patent expirations Drug patent expirations by year for ACETAMINOPHEN AND IBUPROFEN](/p/graph/s/t/ACETAMINOPHEN_AND_IBUPROFEN-patent-expirations.png)
Recent Clinical Trials for ACETAMINOPHEN AND IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Phase 4 |
Jessyka Lighthall | Phase 3 |
Rutgers, The State University of New Jersey | Phase 4 |
Pharmacology for ACETAMINOPHEN AND IBUPROFEN
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |